1. Home
  2. VTOL vs PHAR Comparison

VTOL vs PHAR Comparison

Compare VTOL & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bristow Group Inc.

VTOL

Bristow Group Inc.

HOLD

Current Price

$46.00

Market Cap

1.2B

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

N/A

Current Price

$16.30

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VTOL
PHAR
Founded
1948
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
VTOL
PHAR
Price
$46.00
$16.30
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$58.00
$39.00
AVG Volume (30 Days)
173.9K
18.5K
Earning Date
05-05-2026
03-12-2026
Dividend Yield
1.08%
N/A
EPS Growth
34.58
N/A
EPS
4.32
N/A
Revenue
$1,490,512,000.00
N/A
Revenue This Year
$11.64
$10.04
Revenue Next Year
$5.59
$2.70
P/E Ratio
$10.71
$3,041.22
Revenue Growth
5.30
N/A
52 Week Low
$25.11
$7.50
52 Week High
$49.55
$21.34

Technical Indicators

Market Signals
Indicator
VTOL
PHAR
Relative Strength Index (RSI) 57.31 50.30
Support Level $42.83 $14.88
Resistance Level $46.36 $17.70
Average True Range (ATR) 1.21 0.70
MACD 0.17 0.15
Stochastic Oscillator 88.03 55.67

Price Performance

Historical Comparison
VTOL
PHAR

About VTOL Bristow Group Inc.

Bristow Group Inc is the provider of vertical flight solutions. The group provides aviation services to a broad base of offshore energy companies and government entities. Its business comprises three reportable segments: Offshore Energy Services, Government Services, and Other Services. Its customers in Australia, Brazil, Canada, Chile, the Dutch Caribbean, the Falkland Islands, India, Ireland, the Kingdom of Saudi Arabia, Mexico, the Netherlands, Nigeria, Norway, Spain, Suriname, Trinidad, the UK, and the U.S. offshore energy customers use services to transport personnel to, from and between offshore energy installations.

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

Share on Social Networks: